KR100922605B1 - 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 - Google Patents

바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 Download PDF

Info

Publication number
KR100922605B1
KR100922605B1 KR1020087005140A KR20087005140A KR100922605B1 KR 100922605 B1 KR100922605 B1 KR 100922605B1 KR 1020087005140 A KR1020087005140 A KR 1020087005140A KR 20087005140 A KR20087005140 A KR 20087005140A KR 100922605 B1 KR100922605 B1 KR 100922605B1
Authority
KR
South Korea
Prior art keywords
treatment
hpv
prevention
hydroxybenzoic acid
virus infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020087005140A
Other languages
English (en)
Korean (ko)
Other versions
KR20080036128A (ko
Inventor
웨이화 친
Original Assignee
솅후아 (광저우) 의약과기유한공사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솅후아 (광저우) 의약과기유한공사 filed Critical 솅후아 (광저우) 의약과기유한공사
Publication of KR20080036128A publication Critical patent/KR20080036128A/ko
Application granted granted Critical
Publication of KR100922605B1 publication Critical patent/KR100922605B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
KR1020087005140A 2005-08-02 2006-07-21 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도 Expired - Fee Related KR100922605B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2005100122870A CN100427082C (zh) 2005-08-02 2005-08-02 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
CN200510012287.0 2005-08-02

Publications (2)

Publication Number Publication Date
KR20080036128A KR20080036128A (ko) 2008-04-24
KR100922605B1 true KR100922605B1 (ko) 2009-10-21

Family

ID=37698614

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087005140A Expired - Fee Related KR100922605B1 (ko) 2005-08-02 2006-07-21 바이러스 감염의 예방 및 치료용 약제를 제조하기 위한하이드록시벤조산 에스테르 및 유사체의 용도

Country Status (21)

Country Link
EP (1) EP1930002B1 (enExample)
JP (1) JP5473328B2 (enExample)
KR (1) KR100922605B1 (enExample)
CN (1) CN100427082C (enExample)
AP (1) AP2658A (enExample)
AU (1) AU2006275232B2 (enExample)
BR (1) BRPI0616536B8 (enExample)
CA (1) CA2617659C (enExample)
CY (1) CY1117480T1 (enExample)
DK (1) DK1930002T3 (enExample)
EA (1) EA016576B1 (enExample)
ES (1) ES2567130T3 (enExample)
HU (1) HUE027244T2 (enExample)
IL (1) IL189162A (enExample)
MX (1) MX2008001673A (enExample)
NZ (1) NZ566153A (enExample)
PL (1) PL1930002T3 (enExample)
SI (1) SI1930002T1 (enExample)
UA (1) UA90159C2 (enExample)
WO (1) WO2007014515A1 (enExample)
ZA (1) ZA200801635B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603522B (zh) * 2011-01-23 2015-04-22 复旦大学 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途
KR101401154B1 (ko) * 2011-02-22 2014-05-30 경희대학교 산학협력단 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
CN103599093B (zh) 2013-11-18 2016-06-01 中国医学科学院生物医学工程研究所 一种抗hpv药物制剂及用途
CN103948729B (zh) * 2014-05-15 2015-09-09 陈欣 一种治疗宫颈糜烂的中药栓剂及其制备方法
CA3008466C (en) 2015-12-18 2023-06-20 Talengen International Limited Method for preventing or treating radiation and chemical damage
EP3395355B1 (en) * 2015-12-18 2026-03-04 Talengen International Limited Plasminogen for use in treating cervical erosion
CN105748506B (zh) * 2016-03-03 2018-08-17 青岛海洋生物医药研究院股份有限公司 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用
JPWO2019087884A1 (ja) * 2017-10-31 2020-11-19 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
JPWO2019087881A1 (ja) * 2017-10-31 2020-10-22 富士フイルム株式会社 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
JPWO2019087888A1 (ja) * 2017-10-31 2020-11-12 富士フイルム株式会社 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー
CN111419833B (zh) * 2020-06-02 2023-04-07 上海爱启医药技术有限公司 没食子酸的药物应用
CN114146078B (zh) * 2020-09-07 2025-09-16 盈科瑞（横琴）药物研究院有限公司 对羟基苯甲酸乙酯抗冠状病毒感染的应用
CN114146082B (zh) * 2020-09-07 2025-09-05 盈科瑞（横琴）药物研究院有限公司 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途
CN112375803B (zh) * 2020-11-16 2024-05-07 石河子大学 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途
CN118489806A (zh) * 2024-05-13 2024-08-16 浙江大学 多酚在制备预防和/或缓解动物锌过载所致肠道免疫应激或肠道损伤制剂中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0819380A1 (en) * 1996-06-07 1998-01-21 Iwao Hishida Bacteriocidal, antibacterial and bacteriostatic composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929985A (en) * 1974-01-18 1975-12-30 Richardson Merrell Inc Anhydrous candicidin foam compositions
JPS62132824A (ja) * 1985-12-05 1987-06-16 Eisai Co Ltd 肝炎への治療剤
SE464167B (sv) * 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
CN1042298C (zh) * 1989-07-31 1999-03-03 安纳利蒂康有限公司 含鬼臼毒的乳膏形式的药物组合物的制备方法
CN1068782A (zh) * 1992-01-30 1993-02-10 展静 轮胎气压报警装置
NL9500216A (nl) * 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
DE19514694A1 (de) * 1995-04-13 1996-10-17 Ina Dr Levi Breitspektrum-Antiinfektivamittel
JPH0959151A (ja) * 1995-08-24 1997-03-04 Kao Corp ＮＦ−κＢ活性化抑制剤
CN1068782C (zh) * 1996-04-18 2001-07-25 中国医药研究开发中心 以栾树提取物为有效组分的抗癌药物及制备方法
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
DK1383512T3 (da) * 2001-05-03 2004-11-15 Farmigea Spa Anvendelse af sucralfat til behandling af cervikal erosion

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0819380A1 (en) * 1996-06-07 1998-01-21 Iwao Hishida Bacteriocidal, antibacterial and bacteriostatic composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bioscience Reports Vol.8(1): 95-102 (1998)*

Also Published As

Publication number Publication date
ES2567130T3 (es) 2016-04-20
EA200800467A1 (ru) 2008-10-30
HK1113747A1 (en) 2008-10-17
IL189162A0 (en) 2008-08-07
SI1930002T1 (sl) 2016-06-30
BRPI0616536A2 (pt) 2012-12-25
CY1117480T1 (el) 2017-04-26
WO2007014515A1 (en) 2007-02-08
BRPI0616536B8 (pt) 2021-05-25
HUE027244T2 (en) 2016-09-28
CA2617659A1 (en) 2007-02-08
AU2006275232B2 (en) 2010-12-02
BRPI0616536B1 (pt) 2020-05-26
MX2008001673A (es) 2008-11-06
EA016576B1 (ru) 2012-06-29
DK1930002T3 (en) 2016-04-11
PL1930002T3 (pl) 2016-07-29
EP1930002A1 (en) 2008-06-11
CN1907276A (zh) 2007-02-07
NZ566153A (en) 2011-07-29
KR20080036128A (ko) 2008-04-24
ZA200801635B (en) 2009-06-24
JP2009502985A (ja) 2009-01-29
CN100427082C (zh) 2008-10-22
UA90159C2 (ru) 2010-04-12
EP1930002A4 (en) 2010-04-21
AP2658A (en) 2013-05-09
AU2006275232A1 (en) 2007-02-08
IL189162A (en) 2014-04-30
JP5473328B2 (ja) 2014-04-16
CA2617659C (en) 2013-02-26
EP1930002B1 (en) 2016-01-06

Similar Documents

Publication Publication Date Title
IL189162A (en) Use of a hydroxybenzoic acid ester and its analogs with at least 3 oh transducers to produce a drug to prevent and treat the HPV virus infection
ES2284250T3 (es) Formulaciones para la prevencion o el tratamiento de enfermedades que afectan a la membrana mucosa o la piel, o para la prevencion del embarazo.
US10137140B2 (en) Therapeutic composition
CN102670588B (zh) 鞣花酸用于制备抗病毒药物的应用
CN103920081A (zh) 一种药物组合物的用途
JP2009502985A5 (enExample)
CN111346081B (zh) 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途
US8044098B2 (en) Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
CN100428930C (zh) 对羟基苯甲酸及其类似物在制备预防和治疗皮肤黏膜病毒性感染药物中的应用
CN101342166B (zh) 羟基苯甲酸酯及其类似物在制备预防和治疗乙型肝炎病毒的药物中的应用
US20180133239A1 (en) Therapeutic composition
CN106177900A (zh) 一种抗人乳头瘤病毒的凝胶及其制备方法
HK1113747B (en) Use of hydroxybenzoic acid ester compounds for the manufacture of a medicament for the prevention and treatment of hpv infection
ES2578902B1 (es) Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
CN103893280B (zh) 拳参提取物在制备抗病毒药物中的应用及其提取方法
JPWO2006011394A1 (ja) 抗原虫剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R15-X000 Change to inventor requested

St.27 status event code: A-3-3-R10-R15-oth-X000

R16-X000 Change to inventor recorded

St.27 status event code: A-3-3-R10-R16-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20120621

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20130927

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20140918

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20150701

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20160720

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20170721

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20181002

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 15

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 16

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20251014

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-OTH-PC1903 (AS PROVIDED BY THE NATIONAL OFFICE); TERMINATION CATEGORY : DEFAULT_OF_REGISTRATION_FEE

Effective date: 20251014

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20251014